These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22218458)

  • 1. Zirconium phosphate nano-platelets: a novel platform for drug delivery in cancer therapy.
    Díaz A; Saxena V; González J; David A; Casañas B; Carpenter C; Batteas JD; Colón JL; Clearfield A; Hussain MD
    Chem Commun (Camb); 2012 Feb; 48(12):1754-6. PubMed ID: 22218458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zirconium phosphate nanoplatelets: a biocompatible nanomaterial for drug delivery to cancer.
    Saxena V; Diaz A; Clearfield A; Batteas JD; Hussain MD
    Nanoscale; 2013 Mar; 5(6):2328-36. PubMed ID: 23392208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-triggered blooming of 'nano-flowers' for tumor intracellular drug delivery.
    Yuan Z; Que Z; Cheng S; Zhuo R; Li F
    Chem Commun (Camb); 2012 Aug; 48(65):8129-31. PubMed ID: 22781702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells.
    Wang YC; Wang F; Sun TM; Wang J
    Bioconjug Chem; 2011 Oct; 22(10):1939-45. PubMed ID: 21866903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-loaded (PEG)₃-PLA nanopolymersomes: effect of solvents and process parameters on formulation development and in vitro study.
    Ayen WY; Garkhal K; Kumar N
    Mol Pharm; 2011 Apr; 8(2):466-78. PubMed ID: 21288047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers.
    Gardikis K; Tsimplouli C; Dimas K; Micha-Screttas M; Demetzos C
    Int J Pharm; 2010 Dec; 402(1-2):231-7. PubMed ID: 20934501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
    Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
    Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery.
    Zhang H; Li F; Yi J; Gu C; Fan L; Qiao Y; Tao Y; Cheng C; Wu H
    Eur J Pharm Sci; 2011 Apr; 42(5):517-26. PubMed ID: 21352909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
    Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
    J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
    Wong HL; Bendayan R; Rauth AM; Xue HY; Babakhanian K; Wu XY
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1372-81. PubMed ID: 16547167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
    Xiong XB; Ma Z; Lai R; Lavasanifar A
    Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy.
    Acharya S; Dilnawaz F; Sahoo SK
    Biomaterials; 2009 Oct; 30(29):5737-50. PubMed ID: 19631377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray triggered release of doxorubicin from nanoparticle drug carriers for cancer therapy.
    Starkewolf ZB; Miyachi L; Wong J; Guo T
    Chem Commun (Camb); 2013 Mar; 49(25):2545-7. PubMed ID: 23423224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A duplex oligodeoxynucleotide-dendrimer bioconjugate as a novel delivery vehicle for doxorubicin in in vivo cancer therapy.
    Lee IH; Yu MK; Kim IH; Lee JH; Park TG; Jon S
    J Control Release; 2011 Oct; 155(1):88-95. PubMed ID: 20854858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment.
    Hyung W; Ko H; Park J; Lim E; Park SB; Park YJ; Yoon HG; Suh JS; Haam S; Huh YM
    Biotechnol Bioeng; 2008 Feb; 99(2):442-54. PubMed ID: 17625788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery.
    Geers B; Lentacker I; Sanders NN; Demeester J; Meairs S; De Smedt SC
    J Control Release; 2011 Jun; 152(2):249-56. PubMed ID: 21362448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct intercalation of cisplatin into zirconium phosphate nanoplatelets for potential cancer nanotherapy.
    Díaz A; González ML; Pérez RJ; David A; Mukherjee A; Báez A; Clearfield A; Colón JL
    Nanoscale; 2013 Dec; 5(23):11456-63. PubMed ID: 24072038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-responsive NIR enhanced drug release from gold nanocages possesses high potency against cancer cells.
    Shi P; Qu K; Wang J; Li M; Ren J; Qu X
    Chem Commun (Camb); 2012 Aug; 48(61):7640-2. PubMed ID: 22735385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.